Elsevier Inc.

SHERPA: Unknown

People

  1. Kris
    Kris
  2. Rusch
    Rusch
  3. Seshan
    Seshan
  4. Park
    Park
  5. Heelan
    Heelan
  6. Ladanyi
    Ladanyi
  7. Riely
    Riely
  8. Schwartz
    Schwartz

Groups

  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Surgery (4)
  4. Thoracic Oncology (4)
  5. Biostatistics Service (3)
  6. Center for Pancreatic Cancer Research (3)
  7. Epidemiology and Biostatistics (3)
  8. GSK Faculty (2)
  9. Human Oncology and Pathogenesis Program (2)
  10. Survivorship Research (2)
Search Within
  1. "2007"
  2. "Surgery"
  3. "Thoracic Oncology"
Formats
  1. Meeting Abstract (4)
Groups
  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Surgery (4)
  4. Thoracic Oncology (4)
  5. Biostatistics Service (3)
  6. Center for Pancreatic Cancer Research (3)

More Groups

People
  1. Mark Kris (4)
  2. Valerie Rusch (4)
  3. Venkatraman Seshan (3)
  4. Bernard Park (2)
  5. Marc Ladanyi (2)
  6. Maureen Zakowski (2)

More People

Years
  1. 2007 (4)
Publications
  1. Journal of Thoracic Oncology (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Riely, G. J.; Seshan, V. E.; Azzoli, C. G.; Kris, M. G.; Rusch, V. W.; Park, B. K.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Meeting Abstract

    Marks, J. L.; Broderick, S.; Seshan, V. E.; Zakowski, M. F.; Li, A.; Wilson, R.; Kris, M. G.; Ladanyi, M.; Rusch, V. W.; Pao, W.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Development of a non-small cell lung cancer (NSCLC) survivorship program: Baseline clinical characteristics and quality of life (QOL)
    Meeting Abstract

    Logue, A. E.; Gawiak, C. T.; Houlihan, N.; McCabe, M.; Rusch, V. W.; Kris, M.; Park, B. J.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save